Example: Heart Attack

Clinical Trials on Paramyotonia Congenita

Total 6 results

    • NCT02251457
      Completed
      Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
      Conditions: Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1
    • NCT02336477
      Completed
      Mexiletine and Non Dystrophic Myotonias
      Conditions: Non-dystrophic Myotonias; Paramyotonia Congenita; Myotonia Congenita
    • NCT00004802
      Completed
      Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
      Conditions: Paralysis, Hyperkalemic Periodic; Hypokalemic Periodic Paralysis; Paramyotonia Congenita
    • NCT01939561
      Completed
      Lamotrigine as Treatment of Myotonia
      Conditions: Dystrophia Myotonica Type 1; Myotonia Congenita; Paramyotonia Congenita; Hyperkalemic Periodic Paralysis; Potassium-Aggravated Myotonia
    • NCT00244413
      Completed
      Characteristics of Nondystrophic Myotonias
      Conditions: Nondystrophic Myotonias; Myotonia Congenita; Myotonic Disorders
    • NCT02045667
      Completed
      Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)
      Conditions: Non Dystrophic Myotonia
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations